Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

Prostate treatment fails to cut hip fracture risk

Treating benign prostatic hyperplasia with 5-? reductase inhibitors does not increase hip fracture risk, a large US study reports.

In the first long-term study of finasteride and bone health, analysis of data from 7,000 men over the age of 45 who had a hip fracture and an equal number of controls found 36% of cases and 35% and controls had a diagnosis of BPH.

Among the 250 patients who had received finasteride, the odds ratio of hip fracture associated with the drug was 0.77 (95% CI, 0.59-1.00; P = .04) and there was no suggestion of a dose-response relationship.

JAMA 2008;300:1660-64

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say